Palvella Therapeutics, Inc. PVLA

Set alert

Price alert · PVLA

All alert types
146.33 USD +0.18 +0.12%

At close · Nov 2

146.33 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
146.33 × 2
Ask
146.75 × 2
141.98 Day range 150.00
71.55 52-week range 161.38
YTD
+39.80%
1 year
+83.28%
Open
146.38
Prev close
146.15
Mkt cap
2.11B
Vol
303.46K
Avg vol
214.17K
EPS
-4.85
P/E
0.00
Div yield
0.00%
More statistics
Low
141.98
High
150.00
Forward P/E
-18.51
Beta
0.00
Short ratio
9.92
Inst. own
105.05%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
141.47
200-d avg
126.93
1y target
228.40

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PVLA has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $10.20MExpenses → Selling, General & Admin: $16.38MExpenses → Research & Development: $50.21MGross Profit → Expenses: $23.12MRevenue → Gross Profit: $23.12MRevenue → Cost of Revenue: $2.78MNet Loss → Expenses: $33.28MOther Income$10.20MGross Profit$23.12MNet Loss$33.28MCost of Revenue$2.78MExpenses$66.60MSelling, General & Admin$16.38MResearch & Development$50.21MRevenue$25.90M

Latest period ending Dec 31, 2025 · select a line to chart its full history

PVLA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-38.60M-14.10M-11.87M-43.47M-51.83M
-41.72M-17.43M18.69M-33.28M-45.74M
-3.71-7.832.17-36.00-57.00
PVLA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
57.98M83.60M7.35M38.63M117.76M
59.56M88.23M7.55M95.49M153.56M
31.58M25.63M11.43M67.56M102.81M
633.00K0013.10M13.84M
27.98M62.61M-74.48M27.93M50.76M
PVLA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-25.01M-10.84M-13.70M-59.93M-7.66M
-660.00K87.09M5.00M7.21M59.13M
-25.62M76.25M-8.70M-79.13M47.33M